39.52 USD
▲+0.51+1.62%
盘后 39.00 +0.28%
2026-08-03
市值
$2.00B
市盈率
—
EPS
-0.59
股息率
—
52 周区间
6.09 – 57.14
成交量
91.60K
Beta
0.56
目标价
44.96
52W 低 6.0952W 高 57.14
价格走势
公司简介
Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck, liver, prostate, pancreatic, esophageal, rectal, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in China, South Korea, Singapore, and Th...